Mayne Pharma reported $196.8M in Sales Revenues for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Ansell ANN:AU $ 1.01B 79.9M
Cochlear COH:AU $ 820.7M 66.3M
CSL CSL:AU $ 6.04B 1.47B
Ecofibre Ltd EOF:AU 15.47M 1.35M
Healius Ltd HLS:AU $ 1.34B 389.5M
Integral Diagnostics Ltd IDX:AU 181.53M 2.58M
Nanosonics Ltd NAN:AU $ 60.65M 715K
Next Science Ltd NXS:AU 5.03M 1.12M
Polynovo Ltd PNV:AU 16.55M 3.95M
Probiotec Ltd PBP:AU 85.16M 7.24M
Ramsay Health Care RHC:AU $ 6.47B 53.5M
ResMed RMD:AU $ 864.5M 30.37M
Sigma Healthcare Ltd SIG:AU 1.77B 18.76M
Sonic Healthcare SHL:AU $ 4.76B 434.64M
Telix Pharmaceuticals Ltd TLX:AU 4.69M 1.78M